Nordstrom, Apple, VMware fall premarket; Deere, HP rise
- Nasdaq opens higher; Tesla leads gains in growth stocks
- Santa Clauss rally? BofA says charts suggest a year-end rally in S&P 500
- Citi's Montagu sees risk for another S&P 500 short squeeze on futures positioning
- Stocks and oil buoyed by hopes of looser Chinese COVID curbs
- Flows suggest investors believe the market has bottomed - we disagree, says BofA
By Peter Nurse
Investing.com -- Stocks in focus in premarket trade on Wednesday, November 23rd. Please refresh for updates.
Nordstrom (NYSE: JWN) stock fell 7.7% after the upstream clothing retailer said net sales at its retail stores fell 3.4% in its third quarter, trimming its net profit forecast for the fiscal year ending January 2023.
HP (NYSE: HPQ) stock rose 3.1% after the PC maker said it expects to cut up to 6,000 jobs by the end of fiscal 2025, or about 12% of its global workforce, cutting costs at a time when sales of personal computers and laptops are sliding.
Deere (NYSE: DE) stock rose 3.7% after the company reported a higher-than-expected quarterly profit on strong sales accelerated by price hikes for its agriculture and construction equipment and forecast higher net income next year.
Apple (NASDAQ: AAPL) stock fell 0.2% after violent protests broke out at the world’s largest iPhone assembly plant, owned by Foxconn, which has already been under strict COVID-19 restrictions for a month.
VMware (NYSE: VMW) stock fell 1.3% after the cloud computing company missed quarterly profit and sales expectations while Broadcom’s $61 billion acquisition deal is now on the radar of Britain's competition regulator.
Credit Suisse (NYSE: CS) stock fell 2.4% after the Swiss banking giant said it expects to lose around $1.6B in the current quarter due to an exodus of wealthy clients.
Manchester United (NYSE: MANU) stock rose 8.4% after its owners, the Glazer family, said it will consider a potential sale of the underperforming club.
Autodesk (NASDAQ: ADSK) stock fell 9.5% after the software company issued disappointing fourth-quarter revenue guidance, citing lower demand for multi-year, up-front contracts.
You May Also Be Interested In
- Apple, Chevron, Biogen fall premarket; Univar, Pinduoduo rise
- BiondVax Pharma (BVXV) reports successful results in preclinical in vivo study of its innovative inhaled COVID-19 NanoAb therapy
- Applied Genetic Technologies (AGTC) Said Syncona Limited Extended Offer to Purchase All Shares at $0.34/Sh
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesCredit Suisse, Raising Prices, Definitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!